Lon­za hits the ex­it on gel and liq­uid cap­sules, of­fload­ing 2 pro­duc­tion sites to NextPhar­ma

With the con­tract man­u­fac­tur­ing mar­ket on a hot streak with the Covid-19 vac­cine roll­out, Lon­za has opened its war chest in re­cent months for a suite of ex­pan­sions. But now, with its fo­cus else­where, the com­pa­ny is look­ing to con­tract its cap­sule of­fer­ings for phar­ma.

The CD­MO gi­ant will of­fload its lipid cap­sule pro­duc­tion sites in Ploërmel, France, and Ed­in­burgh, UK, as part of a plan to ex­it the phar­ma­ceu­ti­cal cap­sules space while main­tain­ing its mar­ket foothold in con­sumer health and nu­tri­tion, the com­pa­ny said Tues­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER